| Application no. and date | 14855074.2 (espacenet) (Federated) (European Patent Register), 20141021 | | Patent/reg. no. and date | DK/EP 3060252, 20191211 | | Publication date | 20160831 | | Priority no. and date | US 201361893814 P, 20131021, US 201461979384 P, 20140414, US 201462012805 P, 20140616 | | EP pub. no. and date |
EP 3060252 20160831 | | Effective date | | | Applicant/owner | Vaccinex, Inc., 1895 Mt. Hope Avenue
Rochester, NY 14620, US | | Applicant ref. no. | 20785DK00 | | Inventor | ZAUDERER, Maurice, 44 Woodland Road
Pittsford
New York 14534, US,
BOWERS, William J., 465 Trailwood Court
Webster
New York 14580, US,
JONASON, Alan, 32 Eastview Terrace
Pittsford
New York 14534, US,
SMITH, Ernest S., 1525 Clover Street
Rochester
New York 14610, US | | Representative | Inspicos P/S, Agern Alle 24 , 2970 Hørsholm | | Opponent | | | IPC Class | A61K 38/00 (2006.01) , A61K 39/395 (2006.01) | | Title | USE OF SEMAPHORIN-4D BINDING MOLECULES FOR TREATING NEURODEGENERATIVE DISORDERS | | Int. application no. | US2014061592 | | Int. publication no. | WO2015061330 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
